NephroGenex, Inc.
CIK 0001338095
Revenue (TTM)
—
FY Mar 2016
Net Income (TTM)
−$21.31M
−35.9% YoY
FY Mar 2016
EPS Diluted (TTM)
—
FY Mar 2016
Gross Margin
—
FY Mar 2016
Operating Margin
—
FY Mar 2016
Net Margin
—
FY Mar 2016
Free Cash Flow (TTM)
—
FY Mar 2016
Cash
$18.83M
FY Mar 2016
Total Debt
—
FY Mar 2016
Shares Outstanding
12.95M sh
FY Mar 2016
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.